HomeInsightsResults

Mercury Laboratories Ltd Quarterly Result

Mercury Laboratories Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Mercury Laboratories Ltd

NSE: MERCURYLABS

Net Profit

₹ 0.5

Last updated on: Nov 24, 2024

Key Highlights

  • The revenue of Mercury Laboratories Ltd for the Sep '24 is ₹ 18.4 crore as compare to the Jun '24 revenue of ₹ 16.83 crore. This represent the growth of 9.328578%.
  • The ebitda of Mercury Laboratories Ltd for the Sep '24 is ₹ 1.52 crore as compare to the Jun '24 ebitda of ₹ 1.76 crore. This represent the decline of -13.636364%.
  • The net profit of Mercury Laboratories Ltd for the Sep '24 is ₹ 0.5 crore as compare to the Jun '24 net profit of ₹ 0.34 crore. This represent the growth of 47.058823%.

Results Analysis

Market Price of Mercury Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Mercury Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024928
21 Nov 2024911.45
19 Nov 2024926.75
18 Nov 2024923.05
14 Nov 2024944.45
13 Nov 2024940.45
12 Nov 2024949.2
11 Nov 2024965.15
08 Nov 2024978.95
07 Nov 2024953.25

Historical Revenue of Mercury Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Mercury Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Mercury Laboratories Ltd

No data available

* All values are in crore

Mercury Laboratories Ltd News Hub

News

Mercury Laboratories schedules board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 No...

Read more

07 Nov 202416:57

News

Mercury Laboratories schedules AGM

Mercury Laboratories announced that the 43th Annual General Meeting (AGM) of the company w...

Read more

25 Jul 202414:42

News

Mercury Laboratories to hold board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 24 Ju...

Read more

18 Jul 202410:37

News

Board of Mercury Laboratories recommends Final Dividend

Mercury Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

28 May 202416:17

News

Mercury Laboratories to discuss results

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 28 Ma...

Read more

24 May 202416:37

News

Mercury Laboratories to hold board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 Fe...

Read more

06 Feb 202419:10

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Mercury Laboratories Ltd Quarterly Result

What is the EPS of Mercury Laboratories Ltd stock?

The Earnings Per Share (EPS) of Mercury Laboratories Ltd is 33.24. An EPS is the amount of net income attributed to each share of a common stock.

How is Mercury Laboratories Ltd EPS calculated?

The EPS of Mercury Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Mercury Laboratories Ltd report its EPS?

Mercury Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Mercury Laboratories Ltd EPS?

Factors that influence the EPS of Mercury Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Mercury Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Mercury Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*